Metronidazole Induced Encephalopathy

Insights

Metronidazole can cause neurological toxicity, including seizures and altered sensorium. This case highlights reversible brain changes in the dentate nuclei and corpus callosum associated with metronidazole-induced encephalopathy.

Area of Science:

  • Neurology
  • Pharmacology
  • Infectious Diseases

Background:

  • Metronidazole is a widely used antimicrobial for anaerobic bacterial and protozoal infections.
  • Neurological toxicity is a recognized, albeit concerning, adverse effect of metronidazole.
  • Increasing case reports underscore the importance of recognizing metronidazole-induced neurotoxicity.

Observation:

  • A 32-year-old male with chronic alcoholism and liver abscesses presented with seizures, peripheral neuropathy (burning feet), and altered mental status.
  • The patient had a history of 6 weeks of metronidazole treatment.
  • Clinical presentation suggested a potential neurological adverse event related to medication.

Findings:

  • Magnetic Resonance Imaging (MRI) of the brain revealed characteristic abnormalities.
  • Specific findings included involvement of the dentate nuclei and the splenium of the corpus callosum.
  • These radiological findings are typical of metronidazole-induced encephalopathy (MIE).

Implications:

  • This case highlights the potential for metronidazole to cause significant, yet reversible, neurological toxicity.
  • Early recognition and diagnosis of metronidazole-induced encephalopathy are crucial for prompt management.
  • Awareness among clinicians is vital, especially in patients with risk factors like chronic alcoholism.

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
892
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
99
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
90
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
103